Dr. Elizabeth Mccullagh's lab at Oklahoma State University focuses on understanding how Fragile X Syndrome affects myelination in the auditory brainstem, which is responsible for sound processing. By examining the role of oligodendrocytes, the cells that create myelin, the lab aims to uncover the biological basis of auditory symptoms in individuals with Fragile X Syndrome. The research also explores potential therapeutic interventions to improve auditory function and promotes inclusivity in scientific research for the autism community.

Dr. Yolanda Vasquez leads a research lab at Oklahoma State University focused on developing innovative drug delivery systems for treating rheumatoid arthritis (RA). The lab’s innovative approach uses gold nanoparticles to create targeted carriers for releasing methotrexate—a common treatment for RA—directly into affected joints. This method aims to enhance treatment effectiveness while minimizing side effects experienced with traditional systemic drug administration.